Decorative arrowsHMSA Provider Resource Center
HomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST Integration
Frequently Asked QuestionsUseful Web SitesContacting HMSA
HMSA Logo
 

Cuvitru (Immune Globulin Subcutaneous [Human], 20% Liquid)

Original Effective Date:
10/01/2015
Current Effective Date:
10/01/2015

 


 

To view the current version of this medical policy, please click the link below:

 

Cuvitru (Immune Globulin Subcutaneous [Human], 20% Liquid) - Commercial and QUEST Integration - December 2017

 

Cuvitru (Immune Globulin Subcutaneous [Human], 20% Liquid) - Akamai Advantage - December 2017

 

To view the full list of active HMSA Specialty Medical Drug Policies, please click here.

 

 

As of 10/1/2015, please click here for previous expired versions of this policy.

 

 

First Published:12/28/2017

Files that are in PDF format can be viewed using the free Adobe Reader or another PDF-reader application.

Decorative arrowsHomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST IntegrationFrequently Asked QuestionsUseful Web SitesContacting HMSA

Non-discrimination notice

Need a language interpreter?

ʻŌlelo Hawaiʻi | Bisaya | 繁體中文 | Ilokano | 日本語 | 한국어 | ພາສາລາວ | Kajin Ṃajōḷ | Lokaiahn Pohnpei | Gagana Sāmoa | Español | Tagalog | Tonga | Foosun Chuuk | Tiếng Việt